S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)

Quanterix Stock Forecast, Price & News

-0.44 (-1.33%)
(As of 01/14/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
201,432 shs
Average Volume
297,340 shs
Market Capitalization
$1.20 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

Quanterix logo

About Quanterix

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.


Quanterix (NASDAQ:QTRX) Sets New 12-Month Low at $31.86
January 14, 2022 |  americanbankingnews.com
Baystate Business: Rent Control (Radio) - Bloomberg
January 12, 2022 |  bloomberg.com
The Math Shows IEHS Can Go To $48 - Nasdaq
November 19, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Analytical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$86.38 million
Book Value
$6.47 per share


Net Income
$-31.53 million
Pretax Margin




Free Float
Market Cap
$1.20 billion
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.09 out of 5 stars

Medical Sector

510th out of 1,417 stocks

Analytical Instruments Industry

12th out of 33 stocks

Analyst Opinion: 3.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -

Quanterix (NASDAQ:QTRX) Frequently Asked Questions

Is Quanterix a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Quanterix stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTRX, but not buy additional shares or sell existing shares.
View analyst ratings for Quanterix
or view top-rated stocks.

How has Quanterix's stock price been impacted by COVID-19?

Quanterix's stock was trading at $18.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, QTRX shares have increased by 76.4% and is now trading at $32.65.
View which stocks have been most impacted by COVID-19

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Tuesday, March 1st 2022.
View our earnings forecast for Quanterix

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) released its quarterly earnings results on Thursday, November, 4th. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.13. The firm had revenue of $26.68 million for the quarter, compared to the consensus estimate of $23.84 million. Quanterix had a negative trailing twelve-month return on equity of 11.88% and a negative net margin of 44.63%. During the same quarter last year, the company earned $0.07 earnings per share.
View Quanterix's earnings history

What price target have analysts set for QTRX?

2 brokerages have issued 12-month price objectives for Quanterix's stock. Their forecasts range from $53.00 to $70.00. On average, they anticipate Quanterix's stock price to reach $61.50 in the next year. This suggests a possible upside of 88.4% from the stock's current price.
View analysts' price targets for Quanterix
or view top-rated stocks among Wall Street analysts.

Who are Quanterix's key executives?

Quanterix's management team includes the following people:

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix CEO Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among Quanterix's employees.

What other stocks do shareholders of Quanterix own?

When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $32.65.

How much money does Quanterix make?

Quanterix has a market capitalization of $1.20 billion and generates $86.38 million in revenue each year. The company earns $-31.53 million in net income (profit) each year or ($1.36) on an earnings per share basis.

How many employees does Quanterix have?

Quanterix employs 314 workers across the globe.

What is Quanterix's official website?

The official website for Quanterix is www.quanterix.com.

Where are Quanterix's headquarters?

Quanterix is headquartered at 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at (617) 301-9400 or via email at [email protected].

This page was last updated on 1/17/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.